172
Views
2
CrossRef citations to date
0
Altmetric
Review Article

Influence of Chronic Kidney Disease on Patients Undergoing Elective Hip and Knee Orthopedic Surgery: A Systematic Review and Meta-Analysis

, , , , , & show all

REFERENCES

  • Mills K, Falchi B, Duckett C, Naylor J. Minimal change in physical activity after lower limb joint arthroplasty, but the outcome measure may be contributing to the problem: a systematic review and meta-analysis. Physiotherapy. 2018;105(1):35–45.
  • Gademan MG, Hofstede SN, Vliet Vlieland TP, Nelissen RG, Marang-van de Mheen PJ. Indication criteria for total hip or knee arthroplasty in osteoarthritis: a state-of-the-science overview. BMC Musculoskelet Disord. 2016;17(1):463.doi:10.1186/s12891-016-1325-z.
  • Chang W, Lv H, Feng C, et al. Preventable risk factors of mortality after hip fracture surgery: systematic review and meta-analysis. Int J Surg. 2018;52:320–328. doi:10.1016/j.ijsu.2018.02.061.
  • Klasan A, Dworschak P, Heyse TJ, et al. COPD as a risk factor of the complications in lower limb arthroplasty: a patient-matched study. Int J Chron Obstruct Pulmon Dis. 2018;13:2495–2499. doi:10.2147/COPD.S161577.
  • Bragg-Gresham J, Morgenstern H, McClellan W, et al. County-level air quality and the prevalence of diagnosed chronic kidney disease in the US Medicare population. PloS One. 2018;13(7):e0200612.doi:10.1371/journal.pone.0200612.
  • Chen C, Xia F, Chen Y, et al. Association between thyroid-stimulating hormone and renal function: a Mendelian randomization study. Kidney Blood Press Res. 2018;43(4):1121–1130. doi:10.1159/000491808.
  • Villain C, Ecochard R, Bouchet JL, et al. Relative prognostic impact of nutrition, anaemia, bone metabolism and cardiovascular comorbidities in elderly haemodialysis patients. Nephrol Dial Transplant. 2018;34(5):848–858.
  • Jovanovich A, Kendrick J. Personalized management of bone and mineral disorders and precision medicine in end-stage kidney disease. Semin Nephrol. 2018;38(4):397–409. doi:10.1016/j.semnephrol.2018.05.009.
  • Augustin ID, Yeoh TY, Sprung J, Berry DJ, Schroeder DR, Weingarten TN. Association between chronic kidney disease and blood transfusions for knee and hip arthroplasty surgery. J Arthroplasty. 2013;28(6):928–931. doi:10.1016/j.arth.2013.02.004.
  • Cavanaugh PK, Chen AF, Rasouli MR, Post ZD, Orozco FR, Ong AC. Complications and mortality in chronic renal failure patients undergoing total joint arthroplasty: a comparison between dialysis and renal transplant patients. J Arthroplasty. 2016;31(2):465–472. doi:10.1016/j.arth.2015.09.003.
  • Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603–605. doi:10.1007/s10654-010-9491-z.
  • McCleery MA, Leach WJ, Norwood T. Rates of infection and revision in patients with renal disease undergoing total knee replacement in Scotland. The J Bone Joint Surg Br. 2010;92(11):1535–1539.
  • Ackland GL, Moran N, Cone S, Grocott MP, Mythen MG. Chronic kidney disease and postoperative morbidity after elective orthopedic surgery. Anesth Analg. 2011;112(6):1375–1381.
  • Kuo LT, Lin SJ, Hsu WH, Peng KT, Lin CL, Hsu RW. The effect of renal function on surgical outcomes of intracapsular hip fractures with osteosynthesis. Arch Orthop Trauma Surg. 2014;134(1):39–45.
  • Graves A, Yates P, Hofmann AO, Farmer S, Ferrari P. Predictors of perioperative blood transfusions in patients with chronic kidney disease undergoing elective knee and hip arthroplasty. Nephrology (Carlton, Vic). 2014;19(7):404–409.
  • Miric A, Inacio MC, Namba RS. Can total knee arthroplasty be safely performed in patients with chronic renal disease? Acta orthopaedica. 2014;85(1):71–78.
  • Miric A, Inacio MC, Namba RS. The effect of chronic kidney disease on total hip arthroplasty. J Arthroplasty. 2014;29(6):1225–1230.
  • Erkocak OF, Yoo JY, Restrepo C, Maltenfort MG, Parvizi J. Incidence of infection and inhospital mortality in patients with chronic renal failure after total joint arthroplasty. J Arthroplasty. 2016;31(11):2437–2441.
  • Kuo FC, Lin PC, Lu YD, Lee MS, Wang JW. Chronic kidney disease is an independent risk factor for transfusion, cardiovascular complication, and thirty-day readmission in minimally invasive total knee arthroplasty. J Arthroplasty. 2017;32(5):1630–1634.
  • Jamsa PP, Oksala NKJ, Eskelinen AP, Jamsen ER. Chronic kidney diseases among patients undergoing elective arthroplasty: Risk groups and the value of serum creatinine. J Arthroplasty. 2018;33(1):230–234.e231.
  • Li Q, Dai B, Yao Y, Song K, Chen D, Jiang Q. Chronic kidney dysfunction can increase the risk of deep vein thrombosis after total hip and knee arthroplasty. Biomed Res Int. 2017;2017:8260487.
  • Suh YS, Won SH, Choi HS, Lee JC, Chun DI, Nho JH, Lee HW, Kim JH. Survivorship and complications after hip fracture surgery in patients with chronic kidney disease. J Korean Med Sci. 2017;32(12):2035–2041.
  • Shohat N, Restrepo C, Allierezaie A, Tarabichi M, Goel R, Parvizi J. Increased postoperative glucose variability is associated with adverse outcomes following total joint arthroplasty. J Bone Joint Surg Am. 2018;100(13):1110–1117. doi:10.2106/JBJS.17.00798.
  • Deegan BF, Richard RD, Bowen TR, Perkins RM, Graham JH, Foltzer MA. Impact of chronic kidney disease stage on lower-extremity arthroplasty. Orthopedics. 2014;37(7):e613–618. doi:10.3928/01477447-20140626-51.
  • Danial M, Hassali MA, Ong LM, Khan AH. Survivability of hospitalized chronic kidney disease (CKD) patients with moderate to severe estimated glomerular filtration rate (eGFR) after experiencing adverse drug reactions (ADRs) in a public healthcare center: a retrospective 3 year study. BMC Pharmacol Toxicol. 2018;19(1):52.
  • Miyaoka D, Imanishi Y, Ohara M, et al. Impaired residual renal function predicts denosumab-induced serum calcium decrement as well as increment of bone mineral density in non-severe renal insufficiency. Osteoporos Int. 2019;30(1):241–249.
  • Sakaura H, Miwa T, Kuroda Y, Ohwada T. Surgical outcomes after laminoplasty for cervical spondylotic myelopathy in patients with renal dysfunction and/or aortic arch calcification. J Neurosurg Spine. 2016;25(4):444–447. doi:10.3171/2016.3.SPINE151411.
  • Jamsa P, Jamsen E, Huhtala H, Eskelinen A, Oksala N. Moderate to severe renal insufficiency is associated with high mortality after hip and knee replacement. Clin Orthop Relat Res. 2018;476(6):1284–1292. doi:10.1007/s11999.0000000000000256.
  • Kildow BJ, Agaba P, Moore BF, Hallows RK, Bolognesi MP, Seyler TM. Postoperative impact of diabetes, chronic kidney disease, hemodialysis, and renal transplant after total hip arthroplasty. J Arthroplasty. 2017;32(9):S135–S140.e1. doi:10.1016/j.arth.2017.01.018.
  • Tonelli M, Wiebe N, Guthrie B, et al. Comorbidity as a driver of adverse outcomes in people with chronic kidney disease. Kidney Int. 2015;88(4):859–866. doi:10.1038/ki.2015.228.
  • Gullion CM, Keith DS, Nichols GA, Smith DH. Impact of comorbidities on mortality in managed care patients with CKD. Am J Kidney Dis. 2006;48(2):212–220. doi:10.1053/j.ajkd.2006.04.083.
  • Egan BM, Li J, Hutchison FN, Ferdinand KC. Hypertension in the United States, 1999 to 2012: progress toward Healthy People 2020 goals. Circulation. 2014;130(19):1692–1699. doi:10.1161/CIRCULATIONAHA.114.010676.
  • Kalaitzidis RG, Elisaf MS. Treatment of hypertension in chronic kidney disease. Curr Hypertens Rep. 2018;20(8):64. doi:10.1007/s11906-018-0864-0.
  • Detournay B, Simon D, Guillausseau PJ, et al. Chronic kidney disease in type 2 diabetes patients in France: prevalence, influence of glycaemic control and implications for the pharmacological management of diabetes. Diabetes Metab. 2012;38(2):102–112. doi:10.1016/j.diabet.2011.11.005.
  • Lok CE, Oliver MJ, Rothwell DM, Hux JE. The growing volume of diabetes-related dialysis: a population based study. Nephrol Dial Transplant. 2004;19(12):3098–3103. doi:10.1093/ndt/gfh540.
  • Bazyluk A, Malyszko J, Zbroch E. Cardiovascular risk in chronic kidney disease: what is new in the pathogenesis and treatment? Postgrad Med. 2018;130(5):461–469. doi:10.1080/00325481.2018.1481714.
  • Bains RS, Kardile M, Mitsunaga L, et al. Does chronic kidney disease affect the mortality rate in patients undergoing spine surgery? J Clin Neurosci. 2017;43:208–213. doi:10.1016/j.jocn.2017.05.014.
  • Ozrazgat-Baslanti T, Thottakkara P, Huber M, et al. Acute and chronic kidney disease and cardiovascular mortality after major surgery. Ann Surg. 2016;264(6):987–996. doi:10.1097/SLA.0000000000001582.
  • Zhang Y, Chen P, Chen J, Wang L, Wei Y, Xu D. Association of low serum potassium levels and risk for all-cause mortality in patients with chronic kidney disease: a systematic review and meta-analysis. Ther Apher Dial. 2018;23(1):22–31.
  • Airy M, Schold JD, Jolly SE, et al. Cause-specific mortality in patients with chronic kidney disease and atrial fibrillation. Am J Nephrol. 2018;48(1):36–45. doi:10.1159/000491023.
  • Lamarche MC, Hopman WM, Garland JS, White CA, Holden RM. Relationship of coronary artery calcification with renal function decline and mortality in predialysis chronic kidney disease patients. Nephrol Dial Transplant. 2018;1–8. doi:10.1093/ndt/gfy183.
  • Ishigami J, Grams ME, Chang AR, Carrero JJ, Coresh J, Matsushita K. CKD and risk for hospitalization with infection: the atherosclerosis risk in communities (ARIC) study. Am J Kidney Dis. 2017;69(6):752–761. doi:10.1053/j.ajkd.2016.09.018.
  • Cheikh Hassan HI, Tang M, Djurdjev O, Langsford D, Sood MM, Levin A. Infection in advanced chronic kidney disease leads to increased risk of cardiovascular events, end-stage kidney disease and mortality. Kidney Int. 2016;90(4):897–904. doi:10.1016/j.kint.2016.07.013.
  • Fukushima K, Takahira N, Uchiyama K, Moriya M, Minato T, Takaso M. The incidence of deep vein thrombosis (DVT) during hip arthroscopic surgery. Arch Orthop Trauma Surg. 2016;136(10):1431–1435. doi:10.1007/s00402-016-2508-7.
  • Rattazzi M, Villalta S, De Lucchi L, et al. Chronic kidney disease is associated with increased risk of venous thromboembolism recurrence. Thromb Res. 2017;160:32–37. doi:10.1016/j.thromres.2017.10.011.
  • Jalal DI, Chonchol M, Targher G. Disorders of hemostasis associated with chronic kidney disease. Semin Thromb Hemost. 2010;36(1):34–40. doi:10.1055/s-0030-1248722.
  • Gill KS, Muntner P, Lafayette RA, et al. Red blood cell transfusion use in patients with chronic kidney disease. Nephrol Dial Transplant. 2013;28(6):1504–1515. doi:10.1093/ndt/gfs580.
  • Fox KM, Yee J, Cong Z, et al. Transfusion burden in non-dialysis chronic kidney disease patients with persistent anemia treated in routine clinical practice: a retrospective observational study. BMC Nephrol. 2012;13:5. doi:10.1186/1471-2369-13-5.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.